Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Japan’s Jul-Sep 2011 Ethical Drug Market Grows 7.7%: IMS Japan
November 15, 2011
-
BUSINESS Otsuka Forms Alliance with Lundbeck in CNS Field
November 14, 2011
-
BUSINESS Top-3 GE Makers Report 10.4% Increase in Sales; Pace Down from Year Before
November 11, 2011
-
REGULATORY MHLW Proposes Raising GE Dispensing Rates to Receive Upper Premiums for GE Dispensing Systems
November 10, 2011
-
REGULATORY Applications for “Regulatory Strategy Consultation” Increasing Rapidly: Mr Isobe of PMDA
November 10, 2011
-
BUSINESS Operating Profit Rate for Top-4 Wholesalers Slips to 0.39% in April-September
November 9, 2011
-
BUSINESS Astellas, RIKEN to Explore, Jointly Develop Novel Drug Targets for AD
November 9, 2011
-
BUSINESS Towa Pharmaceutical Developing Lipitor Generic Version OD Tablets
November 9, 2011
-
BUSINESS Towa Pharmaceutical’s New Business Plan is “Groundwork for Future Progress”
November 8, 2011
-
BUSINESS Suzuken President Ota Says Wholesale Business Recovery Crucial
November 8, 2011
-
BUSINESS 8 of 10 Leading Drug Makers Report Declines in 1st-Half Sales
November 7, 2011
-
REGULATORY CSIMC Subcommittee Approves Proposal to Expand Range of Drugs Subject to Re-pricing
November 4, 2011
-
BUSINESS Eisai President Says Japan, China to Become Key Battlefields for Aricept
November 2, 2011
-
BUSINESS Marketing of Imusera, Telavic to Be Limited to Specialists at First: MTPC
November 2, 2011
-
BUSINESS DSP to Boost Domestic CNS Business for Early Maximization of Lonasen
November 1, 2011
-
BUSINESS Shionogi’s Strength in Japan Weakened by Slack US Results, Overall Sales Down 13.5% in Apr-Sept
November 1, 2011
-
BUSINESS DSP: Strong Yen Contributes to 5.6% Decline in Sales
November 1, 2011
-
REGULATORY Drug-induced Hepatitis Victims, Lawyers Petition Against Establishment of “Third Party Organization”
October 31, 2011
-
ACADEMIA JSGM Calls for Elimination of GE Drug Refusal Option in Prescriptions
October 28, 2011
-
REGULATORY Subcommittee to Recommend Use of Most-recent 3-Year Averages in Drug Cost Calculation
October 27, 2011
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…